Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,693
Closed -$1.74M 1251
2023
Q3
$1.74M Buy
+10,693
New +$1.88M 0.03% 401
2023
Q2
Sell
-9,628
Closed -$1.28M 1229
2023
Q1
$1.28M Buy
+9,628
New +$1.13M 0.02% 485
2022
Q4
Sell
-9,200
Closed -$557K 1170
2022
Q3
$557K Buy
+9,200
New +$594K 0.01% 668
2022
Q2
Sell
-17,720
Closed -$1.34M 1228
2022
Q1
$1.34M Buy
+17,720
New +$1.21M 0.02% 517
2021
Q4
Sell
-22,489
Closed -$1.06M 1346
2021
Q3
$1.06M Buy
+22,489
New +$978K 0.02% 634

Other funds holding ACLS

Stephens Inc's ACLS Position: Q4 2023 in Review

Stephens Inc sold out of Axcelis (ACLS) in Q4 2023, closing a stake of 10,693 shares — an estimated $1.74M sold.

Stephens Inc first reported a position in ACLS in Q3 2021 and held it in 5 quarters. The position peaked at $1.74M in Q3 2023. 421 funds tracked by Wall St. Rank hold ACLS as of Q4 2023.

  • Stephens Inc reported no remaining Axcelis position as of Q4 2023 after selling out during the quarter.
  • Stephens Inc sold 10,693 Axcelis shares in Q4 2023, an estimated $1.74M.
  • Stephens Inc first reported a position in Axcelis in Q3 2021 and held it in 5 quarters.
  • Stephens Inc's Axcelis position peaked at $1.74M in Q3 2023.
  • 421 funds tracked by Wall St. Rank held Axcelis as of Q4 2023.

Based on Stephens Inc's 13F filing for Q4 2023, filed 13 Feb 2024.